During the past decade, UNC Children's Raleigh conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UNC Children's Raleigh" are "Allergic Rhinitis Due to Dermatophagoides Farinae" (1 trials), "Allergic Rhinitis Due to Dermatophagoides Pteronyssinus" (1 trials), "Allergic Rhinitis Due to House Dust Mite" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "UNC Children's Raleigh" in a lesser frequency.

Most popular intervention types in "UNC Children's Raleigh" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Sublingual allergy immunotherapy tablet" (1 trials), "nirmatrelvir" (1 trials) and "ritonavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Children's Raleigh" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UNC Children's Raleigh". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UNC Children's Raleigh, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UNC Children's Raleigh, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".